Search Within

Tarun Kewalramani

  1. "Meeting abstract"
Formats
  1. Meeting Abstract (38)
Groups
  1. Department of Medicine (32)
  2. Hematologic Malignancies, Division of (32)
  3. Center for Hematologic Malignancies (30)
  4. Lymphoma (21)
  5. Survivorship Research (16)
  6. Radiation Oncology, Department of (14)

More Groups

People
  1. Stephen Nimer (24)
  2. Craig Moskowitz (21)
  3. Andrew Zelenetz (19)
  4. Joachim Yahalom (14)
  5. Raymond Comenzo (9)
  6. Virginia Klimek (9)

More People

Years
  1. 2009 (2)
  2. 2008 (2)
  3. 2007 (7)
  4. 2006 (3)
  5. 2005 (5)
  6. 2004 (4)

More Years

Publications
  1. Blood (31)
  2. Biology of Blood and Marrow Transplantation (2)
  3. International Journal of Radiation Oncology, Biology, Physics (2)
  4. Journal of Clinical Oncology (2)
  5. Neuro-Oncology (1)
Publishers
  1. American Society of Hematology (31)
  2. Elsevier Inc. (4)
  3. American Society of Clinical Oncology (2)
  4. Oxford University Press (1)

Results (38)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of temozolomide (TMZ) followed by myeloablative chemotherapy with autologous peripheral blood progenitor cell rescue (APBPCR) for newly diagnosed anaplastic oligodendroglioma: An Oligodendroglioma Study Group trial
    Meeting Abstract

    Kaley, T. J.; Raizer, J. J.; Paleologos, N.; Kewalramani, T.; Grimm, S.; Louis, D. N.; Cairncross, J. G.; Abrey, L. E.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Therapeutic and palliative benefit from single-agent irinotecan in multiply treated and highly refractory cases of lymphoma
    Meeting Abstract

    Caces, D. D.; Halaas, J.; Hamlin, P.; Noy, A.; Kewalramani, T.; Portlock, C. S.; Zelenetz, A. D.; O'Connor, O. A.; Gerecitano, J. F.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Sequential administration of bortezomib, liposomal doxorubicin and dexamethasone (BDD) followed by thalidomide and dexamethasone (TD) results in rapid control of untreated high-risk multiple myeloma (MM) and improves depth of response
    Meeting Abstract

    Landau, H.; Hassoun, H.; Cohen, A.; Hoover, E.; Kewalramani, T.; Boruchov, A.; Klimek, V.; Reich, L.; Riedel, E.; Pandit-Taskar, N.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Influence of post-second-line chemotherapy PET Imaging and involved field radiotherapy prior to high dose therapy on outcomes of relapsed or refractory diffuse large B cell lymphoma
    Meeting Abstract

    Hoppe, B. S.; Moskowitz, C. H.; Zhang, Z.; Kewalramani, T.; Maragulia, J. C.; Rice, R. D.; Reiner, A. S.; Hamlin, P. A.; Zelenetz, A. D.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2008)

    Fulltext@MSK | Save
  • Evaluation of single-dose palifermin to reduce mucositis: Assessment of efficacy and safety in patients (PTS) with hematologic malignancies (HM) receiving autologous peripheral blood progenitor cell (PBPC) transplantation
    Meeting Abstract

    Shea, T.; Kewalramani, T.; Mun, Y.; Jayne, J.; Dreiling, L.
    Biology of Blood and Marrow Transplantation (2007)

    Fulltext@MSK | Save
  • Rituximab maintenance following high dose therapy and autologous stem cell rescue after RICE cytoreduction improves event free and overall survival
    Meeting Abstract

    Rice, R. D.; Moskowitz, C. H.; Kewalramani, T.; Persky, D. O.; Rafferty, B. T.; Maragulia, J. C.; Zelenetz, A. D.
    Blood (2007)

    Fulltext@MSK | Save
  • Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A.; Yahalom, J.; Kewalramani, T.; Tejerina, M.; Zelenetz, A. D.; Moskowitz, C. H.
    Blood (2007)

    Fulltext@MSK | Save
  • Late relapses characterize autologous transplantation (ASCT) in first complete remission (CR) for peripheral T-cell lymphoma (PTCL)
    Meeting Abstract

    Kewalramani, T.; Horwitz, S.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
    Blood (2007)

    Fulltext@MSK | Save
  • Relapsed and primary refractory diffuse large B-Cell lymphoma: Improving outcome by incorporating involved field radiotherapy into a comprehensive second-line high-dose therapy strategy
    Meeting Abstract

    Hoppe, B. S.; Yahalom, J.; Kewalramani, T.; Hamlin, P. A.; Rice, D.; Filippa, D.; Maragulia, J.; Weaver, A.; Moskowitz, C. H.
    Blood (2007)

    Fulltext@MSK | Save
  • Relapsed and primary refractory diffuse large cell lymphoma (DLCL) salvaged with involved field radiotherapy (IFRT) & high dose chemotherapy (HDCT) followed by autologous stem cell transplantation (ASCT)
    Meeting Abstract

    Hoppe, B. S.; Moskowitz, C. H.; Moskowitz, C. S.; Filippa, D. A.; Kewalramani, T.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2007)

    Fulltext@MSK | Save